MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).

Jan 30, 2025 · Find patient medical information for Mircera (methoxy polyethylene glycol-epoetin beta) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, …

Jun 5, 2024 · Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more …

What is Mircera? Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called …

Oct 17, 2024 · Mircera (Methoxy Polyethylene glycol-epoetin beta) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications …

MIRCERA is indicated for the treatment of anaemia associated with chronic kidney disease (CKD). Adult patients on dialysis and adult patients not on dialysis.

Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more deaths …

What is MIRCERA ®? MIRCERA ® is a Continuous Erythropoetin Receptor Activator (C.E.R.A.) indicated for: the treatment of symptomatic anaemia associated with chronic kidney disease …

Jun 26, 2024 · Mircera is a man-made form of a protein normally produced by the kidneys that helps your body produce red blood cells. When your body does not make enough of this …

Apr 15, 2025 · What is Mircera and what is it used for? Mircera is a medicine used to treat the symptoms of anaemia (low levels of red blood cells) in adults and children aged 3 months and …